Our Sponsors

  • Stocks to Watch | ABK | AMD | CLDX | GENZ | CTIC |

    Hot stocks
    Friday April 09, 2010, 8:52 am EST

    Hot Stocks for Friday 04/09/2010 - ABK, AMD, CLDX, GENZ, CTIC

    Dear Traders,

    Hot stocks to watch on Friday 04/09/2010  are
    ABK - Ambac Financial Group Inc.
    AMD - Advanced Micro Devices Inc.
    CLDX - Celldex Therapeutics Inc.
    GENZ - Genzyme Corporation
    CTIC - Cell Therapeutics Inc.


    ABK - Ambac Financial Group (ABK) said fourth-quarter net income was $558.1 million, or $1.93 a share. That compares to a net loss of $2.34 billion, or $8.14 a share, in the same period a year earlier. This will have a mad run tomorrow and will continue the same next week.
    News
    Ambac shares jump after quarterly results
    Source : MarketWatch 

    AMD - $325M gain!!! Yes  that's from Global Foundries spin off which will be reflected as non-cash gains of first quarter. AMD is going to release their Q1 earnings on April 15th. It is a good buy this week to get profit from the spike after the release. It will be high or flat so its a safe investment.
    News
    AMD sees $325M gain from GlobalFoundries spinoff
    Advanced Micro Devices Inc. said Thursday that it would see a $325 million non-cash gain in the quarter ended March 27 from its spinoff of GlobalFoundries Inc.
    Source : Business Journal 

    CLDX - CLDX will be announcing growth plans and trial results of its chief drugs soon. This stock will be a big hit soon after the data gets public. Bio-techs are always my favourites. 2010 objectives of CLDX are 1) Report final Phase 1/2 data from a clinical study of CDX-011
    2) Report additional results from the Phase 1 clinical study of CDX-1307 3)Report preliminary data from the Phase 1/2 study of CDX-1401.
    4)Initiate a randomized Phase 2b clinical study of CDX-1307 in combination with immune modulators in patients with muscle-invasive bladder cancer expressing hCG-beta.
    5) Initiate an expanded Phase 2b clinical study of
    CDX-011 in patients with GPNMB-expressing breast cancer including triple negative disease. So overall a good year for Celldex. Do your research and gain tremendous.

    News
    Positive Phase II Data From CDX-110 In Glioblastoma Results In High Expectations For Celldex (CLDX)
    Source : TWST   

    GENZ - June 16 is a very critical day in the corporate history of Genzyme corporation. Shareholders will be voting for new board members. Carl Icahn has 4 nominees for the board this year. If he is successful in getting his people in the board, the stock price will soar in expectation of a potential sell and some reforms. Carl Icahn is known for entering undervalued companies and try to sell them at higher price. He is trying to do the same in Biogen Idec. But here is another part of the story. 2 of his 4 nominees for Genzyme served same position in Biogen  Idec Inc. (BIIB) which is competitor of Genzyme. This can be a conflict of interest and so they might not win. So with all this outline I gave you, you are encouraged to do some detailed research. It will be advisable to buy some options to make some quick money.
    News
    Genzyme Sets June 16 Date for Annual Meeting of Shareholders
    Genzyme Corporation (NASDAQ: GENZ) announced today that it is moving the company’s annual meeting of shareholders to June 16 from May 20, 2010.
    Genzyme will be reporting its first-quarter earnings results on April 21 and will hold its Analyst Day meeting on May 6.
    Source : Business Wire

    CTIC - Check out the Report on CTIC. It can explode anytime. Big new about to come.

    SIRI - Check out the earlier Alert on SIRI. More uptrend predicted for SIRI. Once it crosses $1, we can see more gains.

    Work smart Today to enjoy your Tomorrow.

    God Bless,
    Be Rich.


0 comments:

Leave a Reply

Latest Posts